A systematic analysis of lncRNA expression in NAFLD and control liver samples found that the levels of MEG3 were significantly decreased in liver tissues of NAFLD patients [123]. This evidence concerns the gene MEG3 and metabolic dysfunction-associated steatotic liver disease.